The estimated Net Worth of Oak Partners, Llc Red is at least $6.48 Milione dollars as of 10 August 2020. Oak Red owns over 30,452 units of Electromed stock worth over $3,927,952 and over the last 13 years Oak sold ELMD stock worth over $2,555,177.
Oak has made over 12 trades of the Electromed stock since 2011, according to the Form 4 filled with the SEC. Most recently Oak sold 30,452 units of ELMD stock worth $230,217 on 10 August 2020.
The largest trade Oak's ever made was selling 262,475 units of Electromed stock on 20 September 2017 worth over $1,973,812. On average, Oak trades about 45,613 units every 231 days since 2011. As of 10 August 2020 Oak still owns at least 222,673 units of Electromed stock.
You can see the complete history of Oak Red stock trades at the bottom of the page.
Oak's mailing address filed with the SEC is 40 RICHARDS AVE., SUITE 300, NORWALK, CT, 06854.
Over the last 14 years, insiders at Electromed have traded over $2,585,226 worth of Electromed stock and bought 684,801 units worth $2,582,707 . The most active insiders traders include Oak Partners, Llc Red, Stephen H. Craney e Kathleen Skarvan. On average, Electromed executives and independent directors trade stock every 84 days with the average trade being worth of $358,798. The most recent stock trade was executed by James L. Cunniff on 1 March 2024, trading 9,000 units of ELMD stock currently worth $137,250.
electromed, inc. is a minnesota-based company (nyse mkt: elmd) and the innovative leader in the development, manufacture, and worldwide sales of the smartvest® airway clearance system. the patented system uses high frequency chest wall oscillation (hfcwo), a better-tolerated alternative to chest physiotherapy (cpt), to deliver vigorous, yet comfortable airway clearance treatment for patients battling the consequences of retained secretions. hfcwo has been clinically proven to clear the lungs of excess mucus, improve and reduce lung infections for individuals suffering from various conditions including atelectasis, copd, bronchiectasis, neuromuscular diseases, and cystic fibrosis. electromed, inc. is accredited by the joint commission and is iso 13485:2003 and iso 9001:2008 certified.
Electromed executives and other stock owners filed with the SEC include: